Memorial Sloan Kettering Cancer Center Thoracic Pathology Program

Overview of the Thoracic Pathology Fellowship

The Thoracic Pathology Fellowship at Memorial Sloan Kettering Cancer Center (MSKCC) is a one-year program that offers comprehensive training in thoracic pathology and is accredited by the Accreditation Council for Graduate Medical Education (ACGME). This program is designed for individuals who have completed training in anatomic pathology and are either certified by or eligible for certification by the American Board of Pathology.

MSKCC is renowned for its expertise in diagnosing pulmonary, pleural, and mediastinal diseases. The fellowship benefits from the collaborative efforts of a multidisciplinary team, which includes thoracic surgeons, oncologists, radiologists, pulmonologists, and molecular biologists, offering fellows a rich and diverse learning environment.

Clinical Rotations

Fellows participate in a structured rotation system that provides exposure to a variety of clinical scenarios:

1. MSKCC Hospital Service

During the hospital service rotation, fellows gain experience by reviewing all thoracic biopsies and resections performed at MSKCC. This includes specimens from the lung, pleura, and mediastinum. The high volume of cases allows fellows to tackle both routine and complex diagnostic challenges, honing their skills in accurate staging, treatment effect assessment, and correlation with radiological and cytological findings.

Furthermore, fellows become proficient in advanced testing methods, such as immunohistochemistry and molecular testing, including MSK-IMPACT for DNA sequencing and MSK-Fusion for RNA sequencing, which are essential for personalized medicine approaches.

2. Consultation Service

This rotation enables fellows to manage a consultation service, where they deal with cases sent for second opinions on challenging neoplastic and non-neoplastic thoracic specimens. The exposure to a wide range of cases, including interstitial lung disease, allows fellows to develop their diagnostic skills alongside senior staff who guide them through complex decision-making processes.

Additionally, fellows have opportunities to integrate radiologic data by reviewing high-resolution CT scans in correlation with histopathology.

3. Translational Research

Engaging in translational research is a pivotal component of the fellowship. Fellows are expected to participate in research projects that culminate in publication or presentation at national conferences. Under the mentorship of thoracic pathologists, fellows have access to a vast repository of clinical material, facilitating comprehensive research opportunities in thoracic diseases.

A digitized consultation study set containing 1000 cases is also provided for educational purposes.

Conferences and Educational Experiences

The program includes participation in various conferences that foster multidisciplinary collaboration. Fellows present cases at the weekly thoracic tumor board, monthly pulmonary and infectious disease conferences, as well as the thoracic pathology consensus conference, interacting with specialists from multiple disciplines.

Application Process and Requirements

Prospective applicants must prepare several documents, including three letters of recommendation addressing the program director, a CV, and a medical school diploma. International medical school graduates must provide proof of their Educational Commission for Foreign Medical Graduates (ECFMG) certification with a “valid indefinitely” statement.

The program has three ACGME-accredited positions available each year, and it welcomes applications from diverse applicants, including DOs and IMGs.

Visa Support

MSKCC provides visa sponsorship for eligible international fellows, enhancing accessibility for qualified candidates from around the globe.

Competitiveness of the Program

The Thoracic Pathology Fellowship at MSKCC is highly competitive, attracting candidates from top training programs. The program values diverse backgrounds and experiences, offering opportunities to candidates holding both MD and DO degrees, as well as international medical graduates who meet the application criteria.